1. Home
  2. RBBN vs MYGN Comparison

RBBN vs MYGN Comparison

Compare RBBN & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ribbon Communications Inc.

RBBN

Ribbon Communications Inc.

N/A

Current Price

$1.35

Market Cap

355.8M

Sector

Technology

ML Signal

N/A

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

N/A

Current Price

$5.55

Market Cap

372.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RBBN
MYGN
Founded
1997
1991
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
355.8M
372.1M
IPO Year
2017
1996

Fundamental Metrics

Financial Performance
Metric
RBBN
MYGN
Price
$1.35
$5.55
Analyst Decision
Strong Buy
Hold
Analyst Count
5
9
Target Price
$3.08
★ $5.90
AVG Volume (30 Days)
976.6K
★ 1.9M
Earning Date
10-27-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 170.97
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $771,400,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$5.15
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 2.33
52 Week Low
$1.28
$2.74
52 Week High
$3.41
$8.09

Technical Indicators

Market Signals
Indicator
RBBN
MYGN
Relative Strength Index (RSI) 39.58 49.85
Support Level $1.30 $4.19
Resistance Level $2.11 $5.52
Average True Range (ATR) 0.10 0.34
MACD -0.00 -0.13
Stochastic Oscillator 7.41 5.24

Price Performance

Historical Comparison
RBBN
MYGN

About RBBN Ribbon Communications Inc.

Ribbon Communications Inc provides communications technology to service providers and enterprises, offering software and high-performance hardware products, network solutions, and services for secure data and voice communications, as well as high-bandwidth networking for residential and enterprise customers across industries such as finance, education, government, utilities, and transportation. It operates through two segments: Cloud and Edge, which generate maximum revenue and deliver software-centric, cloud-native solutions for VoIP, VoLTE, VoNR, and unified communications, and IP Optical Networks, which support growing telecommunications traffic from 5G, distributed cloud computing, and other applications. The Company generates the majority of its revenue from the United States.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

Share on Social Networks: